1. In vitro selection of DNA aptamers recognizing drug-resistant ovarian cancer by cell-SELEX
- Author
-
Dihua Shangguan, Tao Bing, Nan Zhang, Xiao Xiao, Xiangjun Liu, Luyao Shen, Linlin Wang, Yan Wang, Junqing He, Junyan Wang, and Songqing Li
- Subjects
Aptamer ,Cell ,02 engineering and technology ,Drug resistance ,01 natural sciences ,Analytical Chemistry ,Cell Line, Tumor ,medicine ,Humans ,Ovarian Neoplasms ,chemistry.chemical_classification ,Nuclease ,Base Sequence ,biology ,Chemistry ,Cell Membrane ,SELEX Aptamer Technique ,010401 analytical chemistry ,Aptamers, Nucleotide ,021001 nanoscience & nanotechnology ,medicine.disease ,In vitro ,0104 chemical sciences ,medicine.anatomical_structure ,Drug Resistance, Neoplasm ,Cancer research ,biology.protein ,Female ,0210 nano-technology ,Molecular probe ,Glycoprotein ,Ovarian cancer - Abstract
Ovarian cancer is regarded as the most lethal gynecologic malignancy with poor prognosis and high mortality rate. Drug-resistance was thought to be the main obstacle to improving overall survival rate of ovarian cancer. New ligands for drug-resistant ovarian cancer cells have potential for the development of diagnosis and therapy of ovarian cancer. In present work, we reported two aptamers, HF3-58 and HA5-68 generated by cell-SELEX, against a paclitaxel-resistant ovarian cancer cell line (A2780T). Both two aptamers exhibited high selectivity and strong affinity to target cells with low nanomolar dissociation constants. The binding of aptamers to target cells was independent of divalent ions, and was tolerant of incubation temperature and nucleases in serum. Molecular targets of the two aptamers were preliminarily demonstrated to be two different glycoproteins on cell surface of A2780T cells. Owing to the structure stability and high resistance to nuclease, these two aptamers had good performance in the detection of drug-resistant ovarian cancer cells in human serum.
- Published
- 2019